FUNCTION OF SERUM AMYLOID A PROTEIN (SAA)
FUNCTION OF SERUM AMYLOID A PROTEIN (SAA)
批准号:
2080013
负责人:
FREDERICK C. DE BEER
金额:
$17.98万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-08-01 至 1996-07-31
关键词:
amyloidosis apolipoproteins cardiovascular disorder disease /disorder proneness /risk endopeptidases enzyme induction /repression family genetics high density lipoproteins human subject inflammation isoelectric point lipid transport molecular pathology northern blottings protein sequence protein transport restriction fragment length polymorphism rheumatoid arthritis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
During the acute phase response, serum amyloid A protein apolipoprotein,
increases 1,000 fold, and becomes a major component of HDL. In spite of
intense modern interest in the HDL particle, the teleological role of
this alteration of HDL by SAA in acute inflammation is unknown. We
propose that a major role may be facilitation of delivery by HDL of
needed phospholipid in peripheral sites of inflammation, where
consumption of phospholipid in cell membrane destruction, prostonoid
synthesis and the phosphatidyl inositol cell activation pathway is
considerable. Chronic persistence of A-SAA render HDL less capable of
mediating reverse cholesterol transport and provides a molecular
explanation for the increased mortality of patients with chronic active
rheumatoid arthritis from particularly cardiovascular disease. In
addition to acute phase SAA (A-SAA), we have characterized a new SAA
subfamily constitutive on normal HDL (C-SAA). This establishes the
existence of a SAA superfamily with two distinct subfamilies. We propose
that the C-SAA subfamily play a role in the normal biological function of
HDL in that it promotes reverse cholesterol transport by causing the
degradation of apo-AII. We will investigate whether during inflammation,
aberrant induction of C-SAA might cause pathological neutral protease
release with destructive potential. The studies proposed will extend our
understanding of the physiologic role of the SAA's in inflammation and
may help explain the propensity to advanced atherosclerosis in patients
with chronic inflammatory rheumatic diseases.
期刊论文(5)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
--
发表时间:
1995-05
期刊:
Journal of lipid research
影响因子:
6.5
作者:
[C. Banka;T. Yuan;M. Beer;M. Kindy;L. Curtiss;F. D. Beer]
通讯作者:
C. Banka;T. Yuan;M. Beer;M. Kindy;L. Curtiss;F. D. Beer
Structural prerequisites for serum amyloid A fibril formation.
血清淀粉样蛋白 A 原纤维形成的结构先决条件。
DOI:
--
发表时间:
1993
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[deBeer,MC, deBeer,FC, McCubbin,WD, Kay,CM, Kindy,MS]
通讯作者:
Kindy,MS
Mouse serum amyloid A protein (SAA5) structure and expression.
小鼠血清淀粉样蛋白 A 蛋白 (SAA5) 结构和表达。
DOI:
--
发表时间:
1994
期刊:
The Journal of biological chemistry
影响因子:
--
作者:
[deBeer,MC, Kindy,MS, Lane,WS, deBeer,FC]
通讯作者:
deBeer,FC
Serum amyloid A protein enhances the activity of secretory non-pancreatic phospholipase A2.
血清淀粉样蛋白 A 增强分泌型非胰腺磷脂酶 A2 的活性。
DOI:
10.1042/bj3090461
发表时间:
1995
期刊:
The Biochemical journal
影响因子:
--
作者:
[Pruzanski,W, deBeer,FC, deBeer,MC, Stefanski,E, Vadas,P]
通讯作者:
Vadas,P
Serum Amyloid A, Inflammasome Activation, and Abdominal Aortic Aneurysms
-
批准号:9213910
-
项目类别:
-
资助金额:$52.63万
-
财政年份:2017
-
负责人:FREDERICK C. DE BEER
-
依托单位:
HDL Structure and Metabolism During Inflammation
-
批准号:7219726
-
项目类别:
-
资助金额:$32.69万
-
财政年份:2006
-
负责人:FREDERICK C. DE BEER
-
依托单位:
Analytical and Preparative Core
-
批准号:7219730
-
项目类别:
-
资助金额:$21.92万
-
财政年份:2006
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SR-BI MEDIATED SELECTIVE CHOLESTEROL ESTER UPTAKE
-
批准号:6509679
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2001
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SAA and sPLA2 Role in Atherogenesis
-
批准号:6618079
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2001
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SR-BI MEDIATED SELECTIVE CHOLESTEROL ESTER UPTAKE
-
批准号:6866412
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2001
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SAA and sPLA2 Role in Atherogenesis
-
批准号:6442685
-
项目类别:
-
资助金额:$30.15万
-
财政年份:2001
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SAA and sPLA2 Role in Atherogenesis
-
批准号:6779922
-
项目类别:
-
资助金额:$31.5万
-
财政年份:2001
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SR-BI MEDIATED SELECTIVE CHOLESTEROL ESTER UPTAKE
-
批准号:6707547
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2001
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SR-BI MEDIATED SELECTIVE CHOLESTEROL ESTER UPTAKE
-
批准号:6629853
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2001
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SR-BI MEDIATED SELECTIVE CHOLESTEROL ESTER UPTAKE
-
批准号:6286827
-
项目类别:
-
资助金额:$22.05万
-
财政年份:2001
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SAA and sPLA2 Role in Atherogenesis
-
批准号:6528168
-
项目类别:
-
资助金额:$29.5万
-
财政年份:2001
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SPLA2--INFLUENCE ON LIPOPROTEIN METABOLISM
-
批准号:6016820
-
项目类别:
-
资助金额:$17.6万
-
财政年份:1997
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SPLA2--INFLUENCE ON LIPOPROTEIN METABOLISM
-
批准号:6168940
-
项目类别:
-
资助金额:$18.03万
-
财政年份:1997
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SPLA2--INFLUENCE ON LIPOPROTEIN METABOLISM
-
批准号:2376234
-
项目类别:
-
资助金额:$16.6万
-
财政年份:1997
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SPLA2--INFLUENCE ON LIPOPROTEIN METABOLISM
-
批准号:2712161
-
项目类别:
-
资助金额:$17.1万
-
财政年份:1997
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SERUM AMYLOID A PROTEIN--ROLE IN ATHEROGENESIS
-
批准号:2052118
-
项目类别:
-
资助金额:$17.78万
-
财政年份:1994
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SERUM AMYLOID A PROTEIN--ROLE IN ATHEROGENESIS
-
批准号:2052116
-
项目类别:
-
资助金额:$16.66万
-
财政年份:1994
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SERUM AMYLOID A PROTEIN--ROLE IN ATHEROGENESIS
-
批准号:2457544
-
项目类别:
-
资助金额:$18.49万
-
财政年份:1994
-
负责人:FREDERICK C. DE BEER
-
依托单位:
SERUM AMYLOID A PROTEIN--ROLE IN ATHEROGENESIS
-
批准号:2748509
-
项目类别:
-
资助金额:$19.23万
-
财政年份:1994
-
负责人:FREDERICK C. DE BEER
-
依托单位:
海外基金